sermorelin-peptide-virginia-beach The NEMO binding domain peptide is a significant research tool and potential therapeutic agent that targets the NF-κB signaling pathway. This peptide, often referred to as NBD peptide, plays a crucial role in inhibiting inflammation by disrupting the interaction between NEMO (NF-κB Essential Modulator) and the IκB kinase (IKK) complex. Its ability to block NF-κB activation has been explored across various disease models, highlighting its potential in treating inflammatory conditions.
The NEMO binding domain (NBD) is a specific region within the IKKγ protein, which is a key component of the IKK complex. This domain is essential for NEMO to bind to IKKα and IKKβ, thereby regulating the activation of the transcription factor NF-κB.作者：J Chiaravalli·2011·被引用次数：21—Direct inhibition of NF-κB activation bypeptidetargeting the NOA ubiquitinbinding domainofNEMO. Jeanne Chiaravalli (1) , Elisabeth Fontan (1) , Hafida ... NF-κB is a central regulator of immune responses, inflammation, and cell survival, but its dysregulation is implicated in numerous diseases, including cancer, autoimmune disorders, and neurodegenerative conditions.
The NBD peptide is a synthetic peptide designed to mimic this binding interaction. By binding to NEMO or interfering with the NEMO-IKK interface, the NBD peptide effectively prevents the assembly and activation of the IKK complex2006年5月9日—Local treatment with the selective IκB kinase β inhibitorNEMO-binding domain peptideameliorates synovial inflammation. Sander W Tas .... This blockade halts the subsequent degradation of IκB proteins and prevents the translocation of NF-κB to the nucleus, thereby suppressing the expression of pro-inflammatory genes.NEMO-Binding Domain Binding Peptide, Cell-Permeable
Research has demonstrated the therapeutic efficacy of the NEMO binding domain peptide in a range of preclinical models. Its anti-inflammatory properties have been investigated for conditions such as:
* Cerebral Ischemia-Reperfusion Injury: Studies have shown that NBD peptide can exert neuroprotective effects by inhibiting inflammation in the brain following ischemic events.
* Osteoblast Differentiation: The peptide has also been observed to promote osteoblast differentiation, even in the presence of tumor necrosis factor alpha (TNF-α), suggesting a role in bone health and repair.
* Tumor Cell Lines: NBD peptide has been found to inhibit constitutive NF-κB activity in various cancer cell lines, including pancreatic carcinoma, squamous cell carcinoma, and melanoma, indicating its potential as an anti-cancer agent.作者：S Dai·2004·被引用次数：251—NEMOregulates the IKK complex activity through its binding to carboxyl-terminal region of IKKα and IKKβ, termedNEMO-binding domain(NBD). In this regard, a ...
* Synovial Inflammation: Local treatment with NBD peptide has shown promise in ameliorating inflammation in synovial tissues, which is relevant for conditions like arthritis.
* Neuroinflammation: Systemic delivery of NBD peptide has been shown to reduce nigral microglial activation and protect dopaminergic neurons, suggesting its utility in neurodegenerative diseases like Parkinson's.NF-κB inhibitor, NEMO-binding domain peptide attenuates ...
The primary mechanism of action of the NEMO binding domain peptide involves competitively inhibiting the interaction between NEMO and the catalytic subunits of the IKK complex (IKKα and IKKβ)作者：AH Barczewski·2019·被引用次数：33—The structure provides detailed insight into the earlier discovery of a smallpeptideinhibitor of theNEMO/IKKβ interaction, named the “NEMO.... This disruption prevents the phosphorylation and degradation of IκB, which is a critical step in NF-κB activation.
Variations of the NBD peptide exist, often incorporating protein transduction domains (PTDs) such as Antennapedia or TAT. These PTDs enhance the cell permeability of the peptide, allowing for more efficient intracellular delivery and improved efficacy in vivo. Cell-permeable versions are particularly important for studying the peptide's effects in complex biological systems and for developing potential therapeutic strategies. Negative control peptides, often mutated versions of the NBD peptide, are used in research to confirm the specificity of the observed effectsDirect inhibition of NF-κB activation by peptide targeting the ....
The NEMO binding domain peptide represents a promising avenue for developing novel anti-inflammatory and anti-cancer therapies. Ongoing research continues to explore its efficacy, safety, and optimal delivery methods. While preclinical studies have yielded encouraging results, further investigation, including clinical trials, is necessary to fully establish its therapeutic potential in humans. Understanding the precise molecular interactions and downstream effects of NBD peptide engagement remains a key focus for researchers aiming to harness its full therapeutic capacity.
Join the newsletter to receive news, updates, new products and freebies in your inbox.